Janus Henderson Group’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $580M | Buy |
6,134,405
+617,516
| +11% | +$58.4M | 0.28% | 75 |
|
|
2025
Q1 | $346M | Buy |
5,516,889
+3,849,724
| +231% | +$241M | 0.19% | 126 |
|
|
2024
Q4 | $77.5M | Buy |
1,667,165
+624,370
| +60% | +$29M | 0.04% | 305 |
|
|
2024
Q3 | $30M | Sell |
1,042,795
-49,247
| -5% | -$1.42M | 0.02% | 497 |
|
|
2024
Q2 | $15.8M | Sell |
1,092,042
-939,952
| -46% | -$13.6M | 0.01% | 617 |
|
|
2024
Q1 | $32.7M | Buy |
2,031,994
+228,633
| +13% | +$3.67M | 0.02% | 465 |
|
|
2023
Q4 | $35.8M | Buy |
1,803,361
+166,539
| +10% | +$3.31M | 0.02% | 436 |
|
|
2023
Q3 | $26.7M | Buy |
1,636,822
+1,212,266
| +286% | +$19.8M | 0.02% | 479 |
|
|
2023
Q2 | $8.97M | Buy |
424,556
+201,527
| +90% | +$4.26M | 0.01% | 705 |
|
|
2023
Q1 | $4.48M | Sell |
223,029
-315,605
| -59% | -$6.34M | ﹤0.01% | 908 |
|
|
2022
Q4 | $14.1M | Sell |
538,634
-61,366
| -10% | -$1.6M | 0.01% | 641 |
|
|
2022
Q3 | $6.14M | Buy |
+600,000
| New | +$6.14M | ﹤0.01% | 944 |
|